-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2025 Earnings Call Transcript
10 May 2025 12:27 GMT
… of the Investors page on the Crinetics Pharmaceuticals, Inc. website … uncertainties associated with the company’s business. These forward-looking … . These and other market insights continue to highlight … quarterly SG&A investment to increase sequentially …
-
Strong Start for Brazil’s Industry in 2025 Masks Underlying Weakness
09 May 2025 17:58 GMT
… reversed some earlier gains. The Brazilian Institute of Geography and Statistics … industrial segments expanded, led by pharmaceuticals, chemicals, petroleum products, and automotive … weigh on investment and demand.
Strong Start for Brazil’s Industry in 2025 …
-
Generic Drugs Market size is projected to reach USD 594.99 billion by 2031, With growing at a CAGR of 5.0% | The Insight Partners
09 May 2025 14:31 GMT
… and Brazil are … Pharmaceuticals Plc.
Trending Topics: Pharmaceutical Market, Oncology Drugs Market, Antibiotics Market, OTC Drugs Market, Prescription Drugs Market … Announces Investment from Goldman … market
About Us: The Insight Partners is a one stop industry …
-
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
09 May 2025 13:03 GMT
… provide better and safer pharmaceuticals to the markets that we serve.” In … Brazil. The company is currently developing and registering over 100 strategically selected pharmaceutical … both internal R&D investments and licensing-in partnerships to …
-
U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth, 2025-2032 | Athenex, Inc., Avella Specialty
09 May 2025 10:35 GMT
… -to resource for industry leaders, investors, and decision-makers … Market Report:
Central Admixture Pharmacy Services, Inc., Nephron Pharmaceuticals … applications, and potential investment areas
This report delivers … 6 What does a business area's assessment …
-
U.S. Corporate Wellness Market Set to Witness Significant Growth by 2025-2032|Ayco, Aquila, BSDI, Aduro, Active Wellness
09 May 2025 10:31 GMT
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- U.S. Corporate Wellness Market is estimated to be valued at USD 16.07 Bn in 2025 and is expected to reach USD 30.14 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9. …
-
GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Sanofi, Novo Nordisk A/S, AstraZeneca
09 May 2025 10:29 GMT
… resource for industry leaders, investors, and … company, Verrica Pharmaceuticals, AbbVie Inc., Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals … does a business area's … excellence in market research, Coherent Market Insights leads …
-
Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results
09 May 2025 10:30 GMT
… 2025 in the following countries: Brazil, Canada, China, Germany, … several purchase orders from pharmaceutical companies to co- … accessed via the company’s website at investors.embecta.com. … expand in other markets, strengthening our core business, expanding our …
-
U.S. Home Healthcare Market Set to Witness Significant Growth by 2025-2032 | Medline Industries Inc., Medtronic Plc, 3M
09 May 2025 10:23 GMT
… to resource for industry leaders, investors, and decision-makers … applications, and potential investment areas
This report delivers … What does a business area's assessment … -for-Temperature-controlled-Pharmaceuticals-Says-Coherent-Market-Insights.html
Global …
-
Rfid In Healthcare Market Projected To Witness Massive Growth, 2025-2032 | Microchip Technology, Accenture, Hitachi, 3M
09 May 2025 10:13 GMT
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ --
Rfid In Healthcare Market is estimated to be valued at USD 11.9 Bn in 2025 and is expected to reach USD 43.39 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 20.3% …